Join
Live feed
·
INSIDERFilingvia Quantisnow
BridgeBio Pharma Inc. logo

Director Valantine Hannah was granted 3,990 shares, exercised 2,808 shares at a strike of $41.73 and sold $341,524 worth of shares (5,004 units at $68.25) as part of a pre-agreed trading plan, increasing direct ownership by 24% to 9,259 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBIO (BridgeBio Pharma Inc.) and more on Quantisnow.